Tilray Holdings United Kingdom
GPTKB entity
Statements (24)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:Tilray
|
gptkbp:acquisition |
Other cannabis companies
|
gptkbp:brand |
gptkb:Tilray
|
gptkbp:ceo |
gptkb:Irwin_Simon
|
gptkbp:distribution |
Pharmaceutical channels
|
gptkbp:employees |
100+
|
gptkbp:focus |
gptkb:Research_and_development
|
gptkbp:founded |
gptkb:2018
|
gptkbp:has_expansion |
European market
|
gptkbp:headquarters |
gptkb:United_Kingdom
|
https://www.w3.org/2000/01/rdf-schema#label |
Tilray Holdings United Kingdom
|
gptkbp:industry |
gptkb:drug
|
gptkbp:investment |
Cannabis research
|
gptkbp:market |
gptkb:United_Kingdom
|
gptkbp:mission |
Improve patient access to cannabis.
|
gptkbp:parent_company |
Tilray, Inc.
|
gptkbp:partnerships |
Various healthcare providers
|
gptkbp:products |
Cannabis products
|
gptkbp:regulatory_compliance |
UK regulations
|
gptkbp:services |
Medical cannabis services
|
gptkbp:subsidiary |
Tilray, Inc.
|
gptkbp:website |
www.tilray.com
|